Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
BABY's Cash to Debt is ranked higher than
95% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.56 vs. BABY: No Debt )
Ranked among companies with meaningful Cash to Debt only.
BABY' s 10-Year Cash to Debt Range
Min: 0.32  Med: 47.42 Max: No Debt
Current: No Debt
Equity to Asset 0.81
BABY's Equity to Asset is ranked higher than
74% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. BABY: 0.81 )
Ranked among companies with meaningful Equity to Asset only.
BABY' s 10-Year Equity to Asset Range
Min: -1.79  Med: 0.83 Max: 0.94
Current: 0.81
-1.79
0.94
Interest Coverage No Debt
BABY's Interest Coverage is ranked higher than
92% of the 166 Companies
in the Global Medical Devices industry.

( Industry Median: 10000.00 vs. BABY: No Debt )
Ranked among companies with meaningful Interest Coverage only.
BABY' s 10-Year Interest Coverage Range
Min: 4.92  Med: 67.71 Max: 9999.99
Current: No Debt
4.92
9999.99
F-Score: 7
Z-Score: 11.71
M-Score: -2.57
WACC vs ROIC
3.36%
12.28%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 14.05
BABY's Operating margin (%) is ranked higher than
81% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. BABY: 14.05 )
Ranked among companies with meaningful Operating margin (%) only.
BABY' s 10-Year Operating margin (%) Range
Min: -32.53  Med: 3.22 Max: 15.75
Current: 14.05
-32.53
15.75
Net-margin (%) 9.68
BABY's Net-margin (%) is ranked higher than
77% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. BABY: 9.68 )
Ranked among companies with meaningful Net-margin (%) only.
BABY' s 10-Year Net-margin (%) Range
Min: -27.59  Med: 1.33 Max: 14.29
Current: 9.68
-27.59
14.29
ROE (%) 10.28
BABY's ROE (%) is ranked higher than
72% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 3.14 vs. BABY: 10.28 )
Ranked among companies with meaningful ROE (%) only.
BABY' s 10-Year ROE (%) Range
Min: -18.17  Med: 3.09 Max: 10.21
Current: 10.28
-18.17
10.21
ROA (%) 8.13
BABY's ROA (%) is ranked higher than
79% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: -0.33 vs. BABY: 8.13 )
Ranked among companies with meaningful ROA (%) only.
BABY' s 10-Year ROA (%) Range
Min: -11.99  Med: 2.47 Max: 9
Current: 8.13
-11.99
9
ROC (Joel Greenblatt) (%) 50.88
BABY's ROC (Joel Greenblatt) (%) is ranked higher than
89% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. BABY: 50.88 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
BABY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -103.27  Med: 25.31 Max: 72.5
Current: 50.88
-103.27
72.5
Revenue Growth (3Y)(%) 10.30
BABY's Revenue Growth (3Y)(%) is ranked higher than
76% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. BABY: 10.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
BABY' s 10-Year Revenue Growth (3Y)(%) Range
Min: -61.8  Med: 12.00 Max: 38.3
Current: 10.3
-61.8
38.3
» BABY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

BABY Guru Trades in Q2 2014

Jim Simons 405,145 sh (+141.24%)
Diamond Hill Capital 969,630 sh (+0.13%)
Chuck Royce Sold Out
Joel Greenblatt 595,883 sh (-0.10%)
Paul Tudor Jones 24,823 sh (-7.29%)
» More
Q3 2014

BABY Guru Trades in Q3 2014

Ken Fisher 548,495 sh (New)
Paul Tudor Jones 25,620 sh (+3.21%)
Diamond Hill Capital 960,470 sh (-0.94%)
Joel Greenblatt 400,972 sh (-32.71%)
Jim Simons 269,045 sh (-33.59%)
» More
Q4 2014

BABY Guru Trades in Q4 2014

Joel Greenblatt 499,207 sh (+24.50%)
Ken Fisher 585,730 sh (+6.79%)
Jim Simons Sold Out
Diamond Hill Capital 935,868 sh (-2.56%)
Paul Tudor Jones 22,143 sh (-13.57%)
» More
Q1 2015

BABY Guru Trades in Q1 2015

Jim Simons 88,345 sh (New)
Ken Fisher 569,711 sh (-2.73%)
Diamond Hill Capital 881,800 sh (-5.78%)
Paul Tudor Jones 17,137 sh (-22.61%)
Joel Greenblatt 353,746 sh (-29.14%)
» More
» Details

Insider Trades

Latest Guru Trades with BABY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Natus Medical Inc

Diamond Hill Capital Comments on Natus Medical Inc - Oct 17, 2014

Shares of medical device manufacturer Natus Medical, Inc. (BABY) increased after reporting strong quarterly earnings and raising its full-year 2014 earnings guidance. While the company has shown improvement in margins for some time, this was the best quarter of organic revenue growth for Natus in years.

From Diamond Hill Capital (Trades, Portfolio)'s Small Cap Fund Third Quarter 2014 Commentary.

Check out Diamond Hill Capital latest stock trades

Diamond Hill Capital Comments on Natus Medical Inc - Jun 26, 2014

Shares of infant medical device manufacturer Natus Medical, Inc. (BABY) rose as the company reported strong quarterly earnings, continued margin improvement, and a promising outlook for the year.



From Diamond Hill Capital's Small Cap Fund Commentary – First Quarter 2014.



Check out Diamond Hill Capital latest stock trades

Top Ranked Articles about Natus Medical Inc

Diamond Hill Capital Comments on Natus Medical Inc
Shares of medical device manufacturer Natus Medical, Inc. (BABY) increased after reporting strong quarterly earnings and raising its full-year 2014 earnings guidance. While the company has shown improvement in margins for some time, this was the best quarter of organic revenue growth for Natus in years. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 38.80
BABY's P/E(ttm) is ranked lower than
65% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 27.60 vs. BABY: 38.80 )
Ranked among companies with meaningful P/E(ttm) only.
BABY' s 10-Year P/E(ttm) Range
Min: 11.47  Med: 37.61 Max: 723.45
Current: 38.8
11.47
723.45
Forward P/E 25.19
BABY's Forward P/E is ranked lower than
59% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 22.17 vs. BABY: 25.19 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 39.00
BABY's PE(NRI) is ranked lower than
67% of the 154 Companies
in the Global Medical Devices industry.

( Industry Median: 27.80 vs. BABY: 39.00 )
Ranked among companies with meaningful PE(NRI) only.
BABY' s 10-Year PE(NRI) Range
Min: 11.43  Med: 37.61 Max: 699.33
Current: 39
11.43
699.33
P/B 3.79
BABY's P/B is ranked lower than
60% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 3.13 vs. BABY: 3.79 )
Ranked among companies with meaningful P/B only.
BABY' s 10-Year P/B Range
Min: 0.79  Med: 2.29 Max: 5.69
Current: 3.79
0.79
5.69
P/S 3.77
BABY's P/S is ranked lower than
57% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 3.19 vs. BABY: 3.77 )
Ranked among companies with meaningful P/S only.
BABY' s 10-Year P/S Range
Min: 0.95  Med: 2.53 Max: 8.5
Current: 3.77
0.95
8.5
PFCF 30.60
BABY's PFCF is ranked higher than
52% of the 116 Companies
in the Global Medical Devices industry.

( Industry Median: 31.45 vs. BABY: 30.60 )
Ranked among companies with meaningful PFCF only.
BABY' s 10-Year PFCF Range
Min: 12.65  Med: 35.70 Max: 556
Current: 30.6
12.65
556
POCF 27.00
BABY's POCF is ranked lower than
62% of the 149 Companies
in the Global Medical Devices industry.

( Industry Median: 21.48 vs. BABY: 27.00 )
Ranked among companies with meaningful POCF only.
BABY' s 10-Year POCF Range
Min: 10.17  Med: 28.84 Max: 740
Current: 27
10.17
740
EV-to-EBIT 26.33
BABY's EV-to-EBIT is ranked lower than
61% of the 163 Companies
in the Global Medical Devices industry.

( Industry Median: 22.11 vs. BABY: 26.33 )
Ranked among companies with meaningful EV-to-EBIT only.
BABY' s 10-Year EV-to-EBIT Range
Min: -2754.6  Med: 23.20 Max: 409.7
Current: 26.33
-2754.6
409.7
Shiller P/E 95.70
BABY's Shiller P/E is ranked lower than
86% of the 94 Companies
in the Global Medical Devices industry.

( Industry Median: 30.32 vs. BABY: 95.70 )
Ranked among companies with meaningful Shiller P/E only.
BABY' s 10-Year Shiller P/E Range
Min: 19.55  Med: 49.94 Max: 2156
Current: 95.7
19.55
2156
Current Ratio 3.06
BABY's Current Ratio is ranked higher than
55% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 2.69 vs. BABY: 3.06 )
Ranked among companies with meaningful Current Ratio only.
BABY' s 10-Year Current Ratio Range
Min: 1.3  Med: 3.23 Max: 16.01
Current: 3.06
1.3
16.01
Quick Ratio 2.48
BABY's Quick Ratio is ranked higher than
57% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. BABY: 2.48 )
Ranked among companies with meaningful Quick Ratio only.
BABY' s 10-Year Quick Ratio Range
Min: 0.91  Med: 2.51 Max: 15.09
Current: 2.48
0.91
15.09
Days Inventory 97.76
BABY's Days Inventory is ranked higher than
70% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 131.50 vs. BABY: 97.76 )
Ranked among companies with meaningful Days Inventory only.
BABY' s 10-Year Days Inventory Range
Min: 82.54  Med: 119.07 Max: 135.33
Current: 97.76
82.54
135.33
Days Sales Outstanding 83.22
BABY's Days Sales Outstanding is ranked lower than
63% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.21 vs. BABY: 83.22 )
Ranked among companies with meaningful Days Sales Outstanding only.
BABY' s 10-Year Days Sales Outstanding Range
Min: 65.2  Med: 82.60 Max: 112.34
Current: 83.22
65.2
112.34

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 10.23
BABY's Price/Net Current Asset Value is ranked lower than
68% of the 200 Companies
in the Global Medical Devices industry.

( Industry Median: 6.82 vs. BABY: 10.23 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
BABY' s 10-Year Price/Net Current Asset Value Range
Min: 1.09  Med: 5.47 Max: 2050
Current: 10.23
1.09
2050
Price/Tangible Book 8.50
BABY's Price/Tangible Book is ranked lower than
74% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 4.53 vs. BABY: 8.50 )
Ranked among companies with meaningful Price/Tangible Book only.
BABY' s 10-Year Price/Tangible Book Range
Min: 1.02  Med: 4.34 Max: 64.5
Current: 8.5
1.02
64.5
Price/Projected FCF 2.42
BABY's Price/Projected FCF is ranked lower than
62% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. BABY: 2.42 )
Ranked among companies with meaningful Price/Projected FCF only.
BABY' s 10-Year Price/Projected FCF Range
Min: 0.79  Med: 1.53 Max: 9.86
Current: 2.42
0.79
9.86
Price/Median PS Value 1.49
BABY's Price/Median PS Value is ranked lower than
71% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 1.13 vs. BABY: 1.49 )
Ranked among companies with meaningful Price/Median PS Value only.
BABY' s 10-Year Price/Median PS Value Range
Min: 0.13  Med: 0.93 Max: 2.88
Current: 1.49
0.13
2.88
Price/Graham Number 3.84
BABY's Price/Graham Number is ranked lower than
71% of the 134 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. BABY: 3.84 )
Ranked among companies with meaningful Price/Graham Number only.
BABY' s 10-Year Price/Graham Number Range
Min: 1.21  Med: 3.04 Max: 33.06
Current: 3.84
1.21
33.06
Earnings Yield (Greenblatt) (%) 3.80
BABY's Earnings Yield (Greenblatt) (%) is ranked higher than
69% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.50 vs. BABY: 3.80 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
BABY' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.2  Med: 4.00 Max: 17.5
Current: 3.8
0.2
17.5
Forward Rate of Return (Yacktman) (%) 9.69
BABY's Forward Rate of Return (Yacktman) (%) is ranked higher than
67% of the 99 Companies
in the Global Medical Devices industry.

( Industry Median: 4.13 vs. BABY: 9.69 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
BABY' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -1.5  Med: 2.60 Max: 75
Current: 9.69
-1.5
75

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:NM4.Germany,
Natus Medical Inc was incorporated in California in May 1987 and reincorporated in Delaware in August 2000. The Company is a provider of newborn care and neurology healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The Company offers two product families: Neurology and Newborn Care. Neurology includes products for diagnostic electroencephalography (EEG), electromyography (EMG), diagnostic sleep analysis or polysomnography (PSG), intra-operative monitoring (IOM), and transcranial doppler ultrasound technology. Newborn Care includes products for newborn care including hearing screening, brain injury, thermoregulation, jaundice management, and various disposable products, as well as products for diagnostic hearing assessment for children through adult populations, and products to diagnose and assist in treating balance and mobility disorders. The Company is subject to inspection and market surveillance by the FDA to determine compliance with regulatory requirements.
» More Articles for BABY

Headlines

Articles On GuruFocus.com
Diamond Hill Small Cap Fund Q4 2014 Commentary Mar 17 2015 
Diamond Hill Small Cap Fund Third Quarter Letter Oct 25 2014 
Diamond Hill Capital Comments on Natus Medical Inc Oct 17 2014 
Diamond Hill Small Cap Fund Third Quarter 2014 Commentary Oct 17 2014 
Diamond Hill Capital Comments on Natus Medical Inc Jun 26 2014 
Diamond Hill Small Cap Fund Commentary – First Quarter 2014 Jun 25 2014 
Weekly CEO Sells Highlight: OCZ Technology Group Inc, Workday Inc, Gilead Sciences Inc, Natus Medica Dec 09 2013 
Natus Medical Inc. Reports Operating Results (10-Q) Nov 05 2010 
David Nierenberg’s Top Holdings: MOVE, ESIO, BABY, RSYS, HPY, SPN Aug 27 2010 
Natus Medical Inc. (BABY) VP Finance and CFO Steven J Murphy sells 1,814 Shares Aug 19 2010 

More From Other Websites
Natus Medical at 52-Week High, Product Pipeline Holds Key - Analyst Blog Jun 25 2015
Cyberonics Positive on Sorin Merger, Mixed Q4 Disappoints - Analyst Blog Jun 18 2015
Abiomed Looks to Expand, Add New Jobs and Infrastructure - Analyst Blog Jun 17 2015
Walgreens Boots-MDLIVE Expand Digital Telehealth Platform - Analyst Blog Jun 16 2015
Bruker (BRKR) Poised on Portfolio Strength across Segments - Analyst Blog Jun 15 2015
Cyberonics, Sorin Name Designees to Combined Firm Board - Analyst Blog Jun 15 2015
NATUS MEDICAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 10 2015
IDEXX Stumbles on Foreign Currency Woes, CAG Offers Hope - Analyst Blog Jun 10 2015
Natus Announces $20 Million Share Repurchase Program Jun 05 2015
NATUS MEDICAL INC Files SEC form 8-K, Other Events Jun 05 2015
Natus Announces $20 Million Share Repurchase Program Jun 05 2015
Can the Rally in Natus Medical (BABY) Shares Continue? - Tale of the Tape Jun 04 2015
Preliminary Transcript of BABY presentation 1-Jun-15 12:30pm GMT Jun 01 2015
Edited Transcript of BABY presentation 1-Jun-15 12:30pm GMT Jun 01 2015
What Falling Estimates & Price Mean for Syneron Medical (ELOS) - Tale of the Tape May 29 2015
NATUS MEDICAL INC Financials May 27 2015
Mindray: A Strong Sell on Weak Q1 & Estimate Revision - Analyst Blog May 19 2015
The Motley Fool's Top Stock Picks From Last Quarter May 18 2015
Natus to Present at Jefferies 2015 Global Health Care Conference May 18 2015
Natus to Present at Jefferies 2015 Global Health Care Conference May 18 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK